Please select the option that best describes you:
Topics:
Radiation Oncology • Neuro-Oncology
Would you consider adjuvant radiation therapy for a grade 1 meningioma with an elevated Ki67?
Does extent of resection alter your recommendations? If treating, what dose and fractionation would you recommend?
Answer from: Radiation Oncologist at Community Practice
An answer to this important question requires conjecture as well as additional details. Ki-67 has indeed in some studies been identified as a promising biomarker [Liu et al., PMID 32118704, Tjuatja et al., PMID 36448071, Chen et al., PMID 29624151], however not uniformly so [Jensen et al., PMID 2929...
Sign in or Register to read more